Skip to main content
SpringerLink
Log in

Critical Issues in Adolescent Contraception

  • Chapter
  • First Online:
Female and Male Contraception

Part of the book series: Trends in Andrology and Sexual Medicine ((TASM))

  • 1221 Accesses

Abstract

Contraceptive use in early sexual life is an important health target. Adolescents often display an approach to sexuality and a perception of risk-behavior completely different from adults. For these reasons, contraceptive education and counselling require specific competences. Contextual factors, related to family situations, body dissatisfaction and low self-esteem, peer pressure, internet dependency, experiencing an asymmetric relationship, have a significant impact on protective choice and contraceptive adherence and compliance.

Furthermore, we have to consider that adolescents are still in a growing trajectory, also from a biological point of view. Therefore, we propose also a revision of the impact of various contraceptive methods on cervico-vaginal milieu, on the function of hypothalamus-pituitary- ovarian axis, on bone mineral content increase and on mood disorders.

The clinical history of our young patients should focus, with empathy, both on social and emotional situations and changes, on the need of information, and on physical maturation, together with the well-known biological risk factors, in order to direct a proper protective choice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Palmer M, Clarke L, Ploubidis G, Mercer C, Gibson L, Johnson A, Copas A, Weillings K. Is “sexual competence” at first heterosexual intercourse associated with subsequent sexual health status? J Sex Res. 2017;54(1):91–104.

    Article  PubMed  Google Scholar 

  2. Widman L, Noar SM, Choukas-Bradely S, Francis D. Adolescent sexual health communication and condom use: a meta-analysis. Health Psychol. 2014;33(10):1113–24.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Gambadauro P, Carli V, Wasserman C, Hadlaczky G, Sarchiapone M, Apter A, et al. Psychopathology is associated with reproductive health risk in European adolescents. Reprod Health. 2018;15(1):186–95.

    Article  PubMed  PubMed Central  Google Scholar 

  4. London S, Quinn K, Scheidell JD, Frueh BC, Khan MR. Adverse experiences in childhood and sexually transmitted infection risk from adolescence into adulthood. Sex Transm Dis. 2017;44(9):524–32.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Scheidell JD, Quinn K, McGorray SP, Frueh BC, Beharie NN, Cottler LB, Khan MR. Childhood traumatic experiences and the association with marijuana and cocaine use in adolescence through adulthood. Addiction. 2018;113(1):44–56.

    Article  PubMed  Google Scholar 

  6. Chang T, Davis MM, Kusunoki Y, Ela EJ, Hall KS, Barber JS. Sexual behavior and contraceptive use among 18 to 19 year old adolescent women by weight status: a longitudinal analysis. J Pediatr. 2015;167(3):586–92.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Heger JP, Brunner R, Parzer P, Fischer G, Resch F, Kaess M. Depression and risk behavior in adolescence. Prax Kinderpsychol Kinderpsychiatr. 2014;63(3):177–99.

    Article  PubMed  Google Scholar 

  8. Auslander BA, Baker J, Short MB. The connection between young women’s body esteem and sexual assertiveness. J Pediatr Adolesc Gynecol. 2012;25(2):127–30.

    Article  PubMed  Google Scholar 

  9. European Society of Contraception and Reproductive Health Position Paper on Sexual and Reproductive Health and Rights 2019 (The Madrid Declaration). https://eschr.eu.

  10. Titchen KE, Maslyanskaya S, Silver EJ, Coupey SM. Sexting and young adolescents: associations with sexual abuse and intimate partner violence. J Pediatr Adolesc Gynecol. 2019;32(5):481–6.

    Article  PubMed  Google Scholar 

  11. Kawabe K, Horiuchi F, Oka Y, Ueno SI. Association between sleep habits and problems and internet addiction in adolescents. Psichiatry Investig. 2019;16(8):581–7.

    Article  Google Scholar 

  12. Chandra-Mouli V, Plesons M, Adebayo E, Amin A, Kraft JM, Lane C, et al. Implications of the global early adolescent study’s formative research findings for action and for research. J Adolesc Health. 2017;61:55–9.

    Article  Google Scholar 

  13. Miller E, Decker MR, Reed E, Raj A, Hathaway JE, Silverman JG. Male partner pregnancy-promoting behaviors and adolescent partner violence: findings from a qualitative study with adolescent females. Ambul Pediatr. 2007;7(5):360–6.

    Article  PubMed  Google Scholar 

  14. Barrios De Tomasi A, Opata MM, Mowa CN. Immunity in the cervix: interphase between immune and cervical epithelial cells. J Immunol Res. 2019;2019:7693183.

    PubMed  PubMed Central  Google Scholar 

  15. Herfs M, Soong TR, Delvenne P, Crum CP. Deciphering the multifactorial susceptibility of mucosal junction cells to HPV infection and related carcinogenesis. Viruses. 2017;9:85–98.

    Article  PubMed Central  CAS  Google Scholar 

  16. Pudney J, Quayle AJ, Andrson DJ. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod. 2005;73:1253–63.

    Article  CAS  PubMed  Google Scholar 

  17. Hickey RJ, Zhou X, Settles ML, Erb J, Malone K, Hansmann MA, Shew ML, Van Der Pol B, Fortenberry JD, Forney LJ. Vaginal microbiota of adolescent girls prior to the onset of menarche resemble those of reproductive-age women. MBio. 2015;6(2):e00097-15.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Ghosh M, Jais M, Biswas R, Jarin J, Daniels J, Joy C, Juzumaite M, Emmanuel BS, Gomes LV. Immune biomarkers and anti-HIV activity in the reproductive tract of sexually inactive adolescent girls. Am J Reprod Immunol. 2018;79(6):e12846.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Scott ME, Ma Y, Farhat S, Shiboski S, Moscicki AB. Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women: effects of Chlamydia trachomatis infection, hormonal contraception, and smoking. J Clin Immunol. 2006;26(3):222–32.

    Article  CAS  PubMed  Google Scholar 

  20. Brooks JP, Edwards DJ, Blithe DL, Fettweis JM, Serrano MG, Sheth NU, Strauss JF, Buck GA, Jefferson KK. Effects of combined oral contraceptives, depot medroxyprogesterone acetate, and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. Contraception. 2017;95(4):405–14.

    Article  CAS  PubMed  Google Scholar 

  21. Donders GGG, Bellen G, Ruban K, Van Bulck B. Short-and long-term influence of the levonorgestrel-releasing intrauterine system (Myrena) on vaginal microbiota and Candida. J Med Microbiol. 2018;67:308–13.

    Article  CAS  PubMed  Google Scholar 

  22. Eastman AJ, Bergin IL, Chai D, Bassis CM, LeBar W, Oluoch GO, Liechty ER, Nyachieo A, Young VB, Aronoff DM, Patton DL, Bell JD. Impact of the levonorgestrel-releasing intrauterine system on the progression of chlamydia trachomatis infection to pelvic inflammatory disease in a baboon model. J Infect Dis. 2018;217(4):656–66.

    Article  CAS  PubMed  Google Scholar 

  23. Deese J, Pradhan S, Goetz H, Morrison C. Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives. Open Access J Contracept. 2018;9:91–112.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Agenjo González M, Lampaya Nasarre B, Salazar F, Varillas D, Cristobal I. Influence of intrauterine dispositive in human papillomavirus clearance. Eur J Obstet Gynecol Reprod Biol. 2019;232:65–9.

    Article  PubMed  Google Scholar 

  25. Stoddard AM, Xu H, Madden T, Alisworth JE, Peipert JF. Fertility after intrauterine device removal: a pilot study. Eur J Contracept Reprod Health Care. 2015;20(3):223–30.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mendoza RM, Garbers S, Lin S, Stockwell MS, Warren M, Gold MA. Chlamydia infection among adolescent long-acting reversible contraceptive (LARC) and shorter acting hormonal contraceptive users receiving services at New York City school-based health centers. J Pediatr Adolesc Gynecol. 2020;33:53–7.

    Article  PubMed  Google Scholar 

  27. Peña AS, Doherty DA, Atkinson HC, Hickey M, Norman RJ, Hart R. The majority of irregular menstrual cycles in adolescence are ovulatory: results of a prospective study. Arch Dis Child. 2018;103(3):235–9.

    Article  PubMed  Google Scholar 

  28. Sun BZ, Kangarloo T, Adams JM, Sluss PM, Welt CK, Chandler DW, Zava DT, McGrath JA, Umbach DM, Hall JE, Shaw ND. Healthy post-menarchal adolescent girls demonstrate multi-level reproductive axis immaturity. J Clin Endocrinol Metab. 2019;104(2):613–23.

    Article  PubMed  Google Scholar 

  29. Rovner P, Keltz J, Allshouse A, Isaac B, Hickmon C, Lesh J, Chosich J, Santoro N. Induction of the LH surge in premenarchal girls confirms early maturation of the hypothalamic- pituitary-ovarian axis. Reprod Sci. 2018;25(1):33–8.

    Article  CAS  PubMed  Google Scholar 

  30. Legro RS, Lin HM, Demers LM, Lloyd T. Rapid maturation of the reproductive axis during perimenarche independent of body composition. J Clin Endocrinol Metab. 2000;85(3):1021–5.

    CAS  PubMed  Google Scholar 

  31. Zhang K, Pollack S, Ghods A, Dicken C, Isaac B, Adel G, Zeitlian G, Santoro N. Onset of ovulation after menarche in girls: a longitudinal study. J Clin Endocrinol Metab. 2008;93(4):1186–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Van Hoof MHA, Voorhorst FJ, Kaptein MBH, Hirasing RA, Koppenaal C, Schoemaker J. Predictive value of menstrual cycle pattern, body mass index, hormone levels and plycystic ovaries at age 15 years for oligo-amenorrhea at age 18 years. Hum Reprod. 2004;19(2):383–92.

    Article  Google Scholar 

  33. Berglund Scherwitzl E, Lundberg O, Kopp Kallner H, Rowland SP, Holte J, Trussell J, Gemzell Danielsson K, Scherwitzl R. Short- and long-term effect of contraceptive methods on fecundity. Eur J Contracept Reprod Health Care. 2019;24(4):260–5.

    Article  PubMed  Google Scholar 

  34. Girum T, Wasle A. Return of fertility after discontinuation of contraception: a systematic review and meta-analysis. Contracept Reproduct Med. 2018;3:1–9.

    Google Scholar 

  35. Rey-Stocker I, Zufferey MM, Lemarchand MT, Rais M. Sensitivity of the hypophysis, the gonads and the thyroid gland in young girls before and after the use of combined oral contraception. Gynakol Rundsch. 1980;20(3):135–61.

    Article  CAS  PubMed  Google Scholar 

  36. Papageorgiou M, Dolan E, Elliott-Sale KJ, Sale C. Reduced energy availability: implications for bone health in physically active populations. Eur J Nutr. 2018;57(3):847–59.

    Article  PubMed  Google Scholar 

  37. Filippou P, Homburg R. Is foetal hyperexposure to androgens a cause of PCOS? Hum Reprod Update. 2017;23(4):421–32.

    Article  CAS  PubMed  Google Scholar 

  38. Efthymiadou A, Bogiatzidou M, Kritikou D, Chrysis D. Anti-Müllerian hormone in girls with premature adrenarche: the impact of polycystic ovary syndrome history in their mothers. J Pediatr. 2019;205:190–4.

    Article  CAS  PubMed  Google Scholar 

  39. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Mora L, Piltonen T, Norman RJ. On behalf of the International PCOS Network Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–18.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Xue S, Kemal O, Lu M, Lix LM, Leslie WD, Yang S. Age at attainment of peak bone mineral density and its associated factors: The National Health and Nutrition Examination Survey 2005–2014. Bone. 2019;131:115–23.

    Google Scholar 

  41. Weaver CM, Gordon CM, Janz KF, Kalkwarf HJ, Lappe JM, Lewis R, O’Karma M, Wallace TC, Zemel BS. The National Osteoporosis Foundations ’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteporos Int. 2016;27:1281–386.

    Article  CAS  Google Scholar 

  42. Goshtasebi A, Subotic Brajic T, Scholes D, Beres Lederer Goldberg T, Berenson A, Prior JC. Adolescent use of combined hormonal contraception and peak bone mineral density accrual: a meta-analysis of international prospective controlled studies. Clin Endocrinol. 2019;90(4):517–24.

    Article  CAS  Google Scholar 

  43. Di Iorgi N, Maruca K, Patti G, Mora S. Update on bone density measurements and their interpretation in children and adolescents. Best Pract Res Clin Endocrinol Metab. 2018;32(4):477–98.

    Article  PubMed  Google Scholar 

  44. FSRH Guidelines “Hormonal contraception” January 2019 (amended July 2019) p.25. www.fsrh.org.

  45. Pluchino N, Santoro A, Casarosa E, Wenger JM, Genazzani AD, Petignat P, et al. Advances in neurosteroids: role in clinical practice. Climacteric. 2013;16:8–17.

    Article  CAS  PubMed  Google Scholar 

  46. Pluchino N, Ansaldi Y, Genazzani AR. Brain intracrinology of allopregnanolone during pregnancy and hormonal contraception. Horm Mol Biol Clin Invest. 2019;37:1.

    Google Scholar 

  47. Gingnell M, Engman J, Frick A, Moby L, Wikström J, Fredrikson M, Sundström-Poromaa I. Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill—a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology. 2013;38(7):1133–44.

    Article  CAS  PubMed  Google Scholar 

  48. Petersen N, Touroutoglou A, Andreano JM, Cahill L. Oral contraceptive pill use is associated with localized decreases in cortical thickness. Hum Brain Mapp. 2015;36(7):2644–54.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Lewis CA, Kimmig AS, Zsido RG, Jank A, Derntl B, Sacher J. Effects of hormonal contraceptives on mood: a focus on emotion recognition and reactivity, reward processing, and stress response. Curr Psychiatry Rep. 2019;21(11):115.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Hamstraa DA, de Kloetc ER, de Rovera M, Van der Doesa W. Oral contraceptives positively affect mood in healthy PMS-free women: a longitudinal study. J Psychosom Res. 2017;103:119–26.

    Article  Google Scholar 

  51. Schreiber G, Golan M, Avissar S. Beta-arrestin signaling complex as a target for antidepressants and as a depression marker. Drug News Perspect. 2009;22:467–80.

    CAS  PubMed  Google Scholar 

  52. Smith K, Nayyar S, Rana T, Archibong AE, Looney KR, Nayyar T. Do progestin-only contraceptives contribute to the risk of developing depression as implied by beta-arrestin 1 levels in leukocytes? A pilot study. Int J Environ Res Public Health. 2018;15(9):1–21.

    Article  CAS  Google Scholar 

  53. Aleknaviciute J, Tulen JHM, De Rijke YB, Bouwkamp CG, van der Kroeg M, Timmermans M, Kushner SA. The levonorgestrel-releasing intrauterine device potentiates stress reactivity. Psychoneuroendocrinology. 2017;80:39–45.

    Article  CAS  PubMed  Google Scholar 

  54. Merki-Feld GS, Apter D, Bartfai G, Grandi G, Haldre K, Lech M, et al. ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives. Eur J Contracept Reprod Health Care. 2017;22(4):247–9.

    Article  CAS  PubMed  Google Scholar 

  55. Robakis T, Williams KE, Nutkiewicz L, Rasgon NL. Hormonal contraceptives and mood: review of the literature and implications for future research. Curr Psychiatry Rep. 2019;21(7):57.

    Article  PubMed  Google Scholar 

  56. Shen Y, Varma DS, Zheng Y, Boc J, Hu H. Age at menarche and depression: results from the NHANES 2005–2016. PeerJ. 2019;7:e7150.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Worly BL, Gur TL, Schaffir J. The relationship between progestin hormonal contraception and depression: a systematic review. Contraception. 2018;97(6):478–89.

    Article  CAS  PubMed  Google Scholar 

  58. Cromer BA, Smith RD, Blair JM, Dwyer J, Brown RT. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception. Pediatrics. 1994;94(5):687–94.

    Article  CAS  PubMed  Google Scholar 

  59. Harel Z, Biro FM, Kollar LM. Depo-Provera in adolescents: effects of early second injection or prior oral contraception. J Adolesc Health. 1995;16(5):379–84.

    Article  CAS  PubMed  Google Scholar 

  60. Gupta N, O’Brien R, Jacobsen LJ, Davis A, Zuckerman A, Supran S, Kulig J. Mood changes in adolescents using depot-medroxyprogesterone acetate for contraception: a prospective study. J Pediatr Adolesc Gynecol. 2001;14(2):71–6.

    Article  CAS  PubMed  Google Scholar 

  61. Westhoff C, Wieland D, Tiezzi L. Depression in users of depo-medroxyprogesterone acetate. Contraception. 1995;51(6):351–4.

    Article  CAS  PubMed  Google Scholar 

  62. Berenson AB, Tan A, Hirth JM. Complications and continuation rates associated with 2 types of long-acting contraception. Am J Obstet Gynecol. 2015;212(6):761–6.

    Article  PubMed  Google Scholar 

  63. Ott MA, Shew ML, Ofner S, Tu W, Fortenberry JD. The influence of hormonal contraception on mood and sexual interest among adolescents. Arch Sex Behav. 2008;37(4):605–13.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Zettermark S, Perez Vicente R, Merlo J. Hormonal contraception increases the risk of psychotropic drug use in adolescent girls but not in adults: a pharmaco-epidemiological study on 800,000 Swedish women. PLoS One. 2018;3(3):e0194773.

    Article  CAS  Google Scholar 

  65. Funk S, Miller MM, Mishell DR, Archer DF, Poindexter A, Schmidt J, Zampaglione E. Safety and efficacy of Implanon™, a single-rod implantable contraceptive containing etonogestrel. Contraception. 2005;71(5):319–26.

    Article  CAS  PubMed  Google Scholar 

  66. Sznajder KK, Tomaszewski KS, Burke AE, Trent M. Incidence of discontinuation of long-acting reversible contraception among adolescent and young adult women served by an urban, primary care clinic katharine. J Pediatr Adolesc Gynecol. 2017;30(1):53–7.

    Article  PubMed  Google Scholar 

  67. Nelson AL, et al. Exp Opin Drug Deliv. 2017;14(9):1131–40.

    Article  CAS  Google Scholar 

  68. Paterson H, Ashton J, Harrison-Woolrych M. A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents. Contraception. 2009;79(6):433–8.

    Article  CAS  PubMed  Google Scholar 

  69. Chi C, Pollard D, Tuddenham EG, Kadir RA. Menorrhagia in adolescents with inherited bleeding disorders. J Pediatr Adolesc Gynecol. 2010;23(4):215–22.

    Article  PubMed  Google Scholar 

  70. Pillai M, O’Brien K, Hill E. The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities. BJOG. 2010;117(2):216–21.

    Article  CAS  PubMed  Google Scholar 

  71. Lu M, Yang X. Levonorgestrel-releasing intrauterine system for treatment of heavy menstrual bleeding in adolescents with Glanzmann’s Thrombasthenia: illustrated case series. BMC Womens Health. 2018;18(1):45.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Elovainio M, Teperi J, Aalto AM, Grenman S, Kivelä A, et al. Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system. Int J Behav Med. 2007;14(2):70–5.

    Article  PubMed  Google Scholar 

  73. Tazegül Pekin A, Seçilmiş Kerimoğlu Ö, Kebapcılar AG, Yılmaz SA, Benzer N, Çelik Ç. Depressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational study. Arch Gynecol Obstet. 2014;290(3):507–11.

    Article  PubMed  CAS  Google Scholar 

  74. Slattery J, Morales D, Pinheiro L, Kurz X. Cohort study of psychiatric adverse events following exposure to levonorgestrel-containing intrauterine devices in UK general practice. Drug Saf. 2018;41(10):951–8.

    Article  CAS  PubMed  Google Scholar 

  75. Pagano HP, Zapata LB, Berry-Bibee EN, Nanda K, Curtis KM. Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review. Contraception. 2016;94(6):641–9.

    Article  CAS  PubMed  Google Scholar 

  76. Duke JM, Sibbritt DW, Young AF. Is there an association between the use of oral contraception and depressive symptoms in young Australian women? Contraception. 2007;75(1):27–31.

    Article  CAS  PubMed  Google Scholar 

  77. O’Connell K, Davis AR, Kerns J. Oral contraceptives: side effects and depression in adolescent girls. Contraception. 2007;75(4):299–304.

    Article  PubMed  CAS  Google Scholar 

  78. Bitzer J, Rapkin A, Soares CN. Managing the risks of mood symptoms with LNG-IUS: a clinical perspective. Eur J Contracept Reprod Health Care. 2018;23(5):321–5.

    Article  CAS  PubMed  Google Scholar 

  79. Gemzell-Danielsson K, Apter D, Dermout S, Faustmann T, Rosen K, Schmelter T, et al. Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use. Eur J Obstet Gynecol Reprod Biol. 2017;210:22–8.

    Article  CAS  PubMed  Google Scholar 

  80. Skovlund CW, Kessing LV, Mørch LS, Lidegaard Ø. Increase in depression diagnoses and prescribed antidepressants among young girls. A national cohort study 2000–2013. Nord J Psychiatry. 2017;71(5):378–85.

    Article  PubMed  Google Scholar 

  81. Skovlund CW, Mørch LS, Kessing LV, Lange T, Lidegaard Ø. Association of hormonal contraception with suicide attempts and suicides. Am J Psychiatry. 2018;175(4):336–42.

    Article  PubMed  Google Scholar 

  82. Oinonen KA, Mazmanian D. To what extent do oral contraceptives influence mood and affect? J Affect Disord. 2002;70(3):229–40.

    Article  CAS  PubMed  Google Scholar 

  83. Zethraeus N, Dreber A, Ranehill E, Blomberg L, Labrie F, von Schoultz B. A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial. Fertil Steril. 2017;107(5):1238–45.

    Article  CAS  PubMed  Google Scholar 

  84. de Wit AE, Booij SH, Giltay EJ, Joffe H, Schoevers RA, Oldehinkel AJ. Association of use of oral contraceptives with depressive symptoms among adolescents and young women. JAMA Psychiatr. 2019;77:52–9.

    Article  Google Scholar 

  85. McKetta S, Keyes KM. Oral contraceptive use and depression among adolescents. Ann Epidemiol. 2019;29:46–51.

    Article  PubMed  Google Scholar 

  86. Pluchino N, Luisi M, Lenzi E, Centofanti M, Begliuomini S, Freschi R, Ninni F, Genazzani AR. Progesterone and progestins: effect on brain, allopregnanolone and betaendorphin. J Steroid Biochem Mol Biol. 2006;102(1–5):205–13.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Florence, Firenze, FI, Italy

    Vincenzina Bruni & Metella Dei

Authors
  1. Vincenzina Bruni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Metella Dei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vincenzina Bruni .

Editor information

Editors and Affiliations

  1. Department of Medical and Surgical Science, University of Bologna, Clinic of Gynecology and Physiopathology of Reproduction, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

    Maria Cristina Meriggiola

  2. Department of Women’s and Children’s Health, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden

    Kristina Gemzell-Danielsson

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bruni, V., Dei, M. (2021). Critical Issues in Adolescent Contraception. In: Meriggiola, M.C., Gemzell-Danielsson, K. (eds) Female and Male Contraception. Trends in Andrology and Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-70932-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-70932-7_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-70931-0

  • Online ISBN: 978-3-030-70932-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation